Listed

Aspire-Lakewood Holdings, Inc.

ASBPNasdaqCIK 1847345HealthcareFiscal year ends Dec 31

Reports and events: 100 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Aspire-Lakewood Holdings, Inc., Reports and events
FiledFormWhat it isAccession number
2026-10-2021:31 ET8-K/A1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-26-047801
2026-09-2921:15 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001493152-26-044908
2026-09-0914:10 ET8-K5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-26-041918
2026-09-0814:10 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-041725
2026-08-1912:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-039135
2026-08-1320:31 ET10-QQuarterly reportPeriod 2026-06-300001493152-26-037819
2026-08-1013:45 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-036777
2026-07-2021:20 ET8-K8.01 Other events0001493152-26-033942
2026-06-2220:35 ET8-K5.07 Shareholder vote results0001493152-26-029599
2026-06-1221:15 ET8-K8.01 Other events0001493152-26-028518
2026-06-1214:26 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-028386
2026-05-1520:16 ET10-QQuarterly reportPeriod 2026-03-310001493152-26-023802
2026-05-1420:05 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-26-023069
2026-05-0812:34 ETDEF 14AProxy statementPeriod 2026-05-080001493152-26-022026
2026-04-2013:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-018018
2026-04-1710:10 ET8-K/A1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-26-017145
2026-04-1621:14 ET8-K1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-26-017115
2026-04-1619:22 ET8-K5.07 Shareholder vote results0001493152-26-017054
2026-04-1612:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-016979
2026-04-1510:30 ET8-K1.01 Entry into a material agreement0001493152-26-016683
2026-04-1018:54 ETS-1/ARegistration statement, amended0001493152-26-016123
2026-04-0821:26 ET10-K/AAnnual report, amendedPeriod 2025-12-310001493152-26-015737
2026-03-3021:57 ET10-KAnnual reportPeriod 2025-12-310001493152-26-013682
2026-02-2421:15 ETDEF 14AProxy statementPeriod 2026-02-240001493152-26-007883
2026-02-1721:16 ETS-1Registration statement0001493152-26-007123
2026-02-1216:45 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-006343
2026-02-0622:25 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-26-005640
2026-01-3022:05 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-26-004543
2026-01-1511:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-26-002326
2026-01-1321:30 ET8-K5.02 Departure or appointment of officers or directors0001493152-26-002057
2026-01-0613:35 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-26-000518
2025-12-0301:58 ETS-1Registration statement0001493152-25-025819
2025-11-1422:01 ET10-Q/AQuarterly report, amendedPeriod 2025-09-300001493152-25-023619
2025-11-1413:20 ET10-QQuarterly reportPeriod 2025-09-300001493152-25-022595
2025-11-1413:00 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-25-022580
2025-11-0521:50 ET8-K5.07 Shareholder vote results0001493152-25-020891
2025-10-1721:15 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001493152-25-018512
2025-09-2621:13 ETS-1/ARegistration statement, amended0001493152-25-015778
2025-09-2621:10 ET8-K3.02 Unregistered sale of equity; 4.01 Change of auditor; 9.01 Financial statements and exhibits0001493152-25-015773
2025-09-2323:08 ETDEF 14AProxy statementPeriod 2025-09-220001493152-25-014523
2025-09-1820:56 ETS-1Registration statement0001493152-25-014085
2025-08-2221:15 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001641172-25-025257
2025-08-1321:02 ET10-QQuarterly reportPeriod 2025-06-300001641172-25-023573
2025-08-1321:01 ET10-Q/AQuarterly report, amendedPeriod 2025-03-310001641172-25-023566
2025-07-3021:29 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001641172-25-021595
2025-06-1821:29 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001641172-25-015653
2025-06-1012:30 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001641172-25-014445
2025-05-1420:45 ET10-QQuarterly reportPeriod 2025-03-310001641172-25-010316
2025-05-1321:21 ETS-1Registration statement0001641172-25-010013
2025-04-3020:57 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001641172-25-007852

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.